Polo-like kinase 1 (PLK1) regulates interferon (IFN) induction by MAVS

Damien Vitour1, Stéphanie Dabo1, Malek Ahmadi Pour1

  • 1Unit of Hepacivirus and Innate Immunity, 75015, Paris, France.

Insights

Polo-like kinase 1 (PLK1) inhibits interferon (IFN) production by binding to the MAVS protein, a key adapter in innate immunity signaling pathways. This discovery reveals PLK1 as a novel regulator of IFN induction.

Area of Science:

  • Immunology
  • Cell Biology
  • Molecular Biology

Background:

  • Mitochondria-bound adapter MAVS is crucial for interferon (IFN) induction via NF-kappaB and IRF3 pathways.
  • MAVS recruits downstream partners like TRAF family members to initiate signaling cascades.

Purpose of the Study:

  • To identify MAVS-interacting proteins and elucidate their role in IFN induction.
  • To investigate the function of Polo-like kinase 1 (PLK1) in regulating MAVS-mediated innate immune responses.

Main Methods:

  • Yeast two-hybrid screening to identify MAVS-binding proteins.
  • Co-immunoprecipitation and Western blotting to analyze protein interactions and phosphorylation.
  • Interferon induction assays in response to various stimuli.
  • RNA interference (RNAi) to deplete PLK1 levels.
  • Cell cycle arrest using nocodazole.

Main Results:

  • The Polo-box domain (PBD) of PLK1 was identified as a MAVS-interacting protein.
  • PLK1 binds to MAVS through both phosphodependent and phosphoindependent mechanisms.
  • PLK1 inhibits MAVS-mediated activation of IRF3 and NF-kappaB pathways, thereby suppressing IFN induction.
  • Depletion of PLK1 enhances IFN induction, particularly under conditions of cell cycle arrest.
  • PLK1's phosphoindependent interaction with MAVS disrupts TRAF3 binding, inhibiting downstream signaling.

Conclusions:

  • PLK1 acts as a novel negative regulator of IFN induction by directly inhibiting MAVS function.
  • The interaction between PLK1 and MAVS offers a potential target for therapeutic interventions to boost innate immunity.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...